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https://doi.org/10.101T-Cell development is a major branch of lymphoid development and a key output of
hematopoiesis, especially in early life, but the molecular requirements for T-cell poten-
tial have remained obscure. Considerable advances have now been made toward solv-
ing this problem through single-cell transcriptome studies, interfaced with in vitro
differentiation assays that monitor potential efficiently at the single-cell level. This
review focuses on a series of recent reports studying mouse and human early T-cell
precursors, both in the developing fetus and in stringently purified postnatal samples
of intrathymic and prethymic T-lineage precursors. Cross-comparison of results reveals
a robustly conserved core program in mouse and human, but with some informative
and provocative variations between species and between ontogenic states. Repeated
findings are the multipotent progenitor regulatory signature of thymus-seeding cells
and the proximity of the T-cell program to dendritic cell programs, especially to plas-
macytoid dendritic cells in humans. © 2021 ISEH – Society for Hematology and Stem
Cells. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)T- and B-lymphocyte developmental processes have
enjoyed particularly in-depth characterization [1−6].
However, relatively little knowledge concerning T cells
has been integrated into current discussions of broader
hematopoietic differentiation. Most single-cell tran-
scriptome analyses of multilineage hematopoietic stem
and progenitor cells, while powerful and sophisticated
[7−12], have undercharacterized lymphoid precursors.
Cells starting the B-cell and natural killer (NK) cell
programs are detected in bone marrow and are often
labeled as general “lymphoid” precursors [13−15], but
benchmarks for initiation of the T-cell program have
been lacking. This is a problem because the pathway
toward T-cell development is intrinsically different
from pathways to B and NK cells. First, it depends onto: Dr. Ellen Rothenberg, Division of Biology &
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6/j.exphem.2020.12.005the microenvironment of the thymus. Also, at least
some T-cell precursors diverge from B-cell precursors
prethymically, in mice and humans [14,16,17].
Recently, multiple single-cell transcriptome publica-
tions have clarified the earliest stages of T-cell devel-
opment. These insights provide an opportunity to link
better the T-cell developmental pathway to the rest of
hematopoiesis.
Several issues contribute to the poor characterization of
T-cell precursors in bone marrow and cord blood. First,
although abundant in blood, T cells are long-lived, and
they undergo extensive proliferation both within the thy-
mus during development and also as part of their function
after they are mature. Thus, their population homeostasis
does not depend on continuous input of large numbers of
precursors. In young mice, the thymus can generate
»5£ 107 cells/day, exporting »106 mature cells/day, from
inputs of just »10 cells/day [18]. Thus, any dedicated T-
lymphoid precursors could be rare in postnatal bone mar-
row and still supply the thymus in steady state. Second,
the thymus is a formidable black box between transcrip-
tional states in bone marrow and blood populations. Thed by Elsevier Inc. This is an open access article under the CC BY-NC-
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T cells but the most immature thymocytes, which are rare
even within the thymus and unfamiliar to most hematolo-
gists and immunologists alike. Third, T-cell development
initiation depends on intense, multiday exposure to Notch
signals that inhibit other lymphoid and myeloid fates as
they push T-cell differentiation forward [19,20]. This
greatly complicates attempts to test single precursors for
T-cell potential simultaneously with other potentials.
While assay systems have been designed [13,21,22], they
all require caveats.
Mice and humans also differ in the timing of their
first waves of T-cell development relative to gestation.
In mice, with a 20-day gestation period, T-cell devel-
opment starts at »day 13, and the thymus makes its
first cohort of mature-type TCRab+ T cells only just
before birth [23]. In humans, on the other hand, T-cell
development starts by 8−9 weeks of gestation, and the
first T cells are mature in the thymus by week 15, less
than halfway through gestation [24]. Neonatal thymec-
tomy is therefore lethal for mice, but not for humans.
Mouse−human differences are relevant because most
understanding of lymphocyte development has come
from complex genetic manipulations and in vivo cell
transfers in mice. In contrast, much of the recent sin-
gle-cell analysis of hematopoietic precursors has
focused on human samples. The cell surface markers
that enrich or define particular developmental stages
also differ between mouse and human. Now, however,
using the common platform of single-cell transcriptom-
ics, it has become possible to bring together insights
from both biological systems to elicit general principles
for the hematopoietic roots of T-cell development.
Overview of T-cell development
T-Cell development is outlined in Figure 1, in the
framework of the mouse thymus [5,6,18,20,25,26] (for
the human system, see [19]). In each cohort of precur-
sors, cells between entry into the thymus and the first
functional expression of T-cell receptor (TCR) com-
plexes are called “pro-T cells,” and their development
depends on Notch signaling. The stages can be subdi-
vided into thymus-settling precursors (TSPs), “early T-
cell precursors” (ETPs), DN2, and DN3 (each with sub-
divisions) (Figure 1). T-Cell identity is determined dur-
ing the pro-T-cell stages, before TCR expression. The
process involved, as recently illuminated by single-cell
analysis, is the focus of this review.
T cells are closely related both to B cells and to innate
lymphoid cells (ILCs), including both helper-type ILCs
and NK cells. The similarities are modular [3]. T cells
share with B cells their mechanisms for generating clon-
ally unique antigen receptor sequences (immunoglobulin
for B cells, TCR for T cells), through Rag1−Rag2-medi-
ated somatic recombination. They share with ILCs nearlyall their effector functions (cytolytic mechanisms and
secretion of particular cytokine combinations) and tran-
scriptional regulators, although ILCs are Rag independent.
Thus, a priori, it is hard to predict whether prethymic pre-
cursors should be more like B cells, more like ILCs, or
more like multipotent precursors with broader potentials.
T-Cell identity involves both positive activation of
T-cell gene expression and loss of access to alternative
pathways. From population studies in the mouse, it is
known that the T-cell transcriptional regulatory pro-
gram begins in the ETP and DN2 stages, substantially
before the TCR gene recombination that occurs in DN3
stage [27−29], and this pattern is shared in humans
(see below) [30]. Important landmarks are known from
purified subpopulation studies. Mouse T-cell precursors
begin expressing T-cell transcription factors, GATA3
and TCF1 (encoded by Tcf7), soon after entering the
thymus, while other transcription factors, including
Ikaros and Runx family factors and basic helix−loop
−helix “E proteins” such as E2A, are expressed even
before entry. Some genes shared between T- and B-
lineage cells, such as Dntt (encoding terminal deoxynu-
cleotidyl transferase), may be expressed in TSPs as
well. However, T-cell lineage-specific genes, such as
those encoding the CD3 chains that provide membrane
anchoring and signaling function for the TCR, are
upregulated only in the late DN2 stage, and the Rag1,
Rag2 recombinase-coding genes turn on even later, in
the DN3 stage.
Within the thymus, the strong Notch ligand presentation
by the environment makes it overwhelmingly likely that
immigrant precursors will generate T-cell progeny; how-
ever, the cells themselves are not intrinsically committed
to do this when they arrive. Instead, for many cell cycles,
their fate as T cells remains completely environment
dependent [21,31−34]. If ETP or DN2 cells are removed
from the thymus and placed in conditions without Notch
signaling, the cells develop into non-T cells instead. In
contrast, normal DN3 cells can no longer make this shift,
but have become intrinsically committed. Further work
has located the transition from multipotency to commit-
ment (assayed at the single-cell level) within the mouse
DN2 stage(s), when the transcription factor Bcl11b is
upregulated [35−37] and multipotent progenitor-associated
transcription factors are downregulated [25] (Figure 1).
Thus, although the undisturbed thymic microenvironment
enforces a T-cell fate on nearly all progenitors that enter
it, the cells themselves do not internalize this pressure into
an intrinsically committed state until after multiple rounds
of proliferation in the thymic microenvironment [37−40].
Single-cell transcriptome analysis has recently shed
light on multiple questions about T-cell development.
It has refined the program of regulatory change seen at
the population level, and while showing conservation
between mouse and human, it has identified some
Figure 1. Stages of mouse T-cell development. Stages of early T-cell development in the postnatal mouse are shown, from TSP to DN3a, in the
context of the full span of intrathymic T-cell development. Color highlights “hematopoietic” stages of T-cell development, the focus of this
review. Intrathymic Notch signaling (red) triggers and sustains proliferation and drives changes in surface phenotype from ETP (early T-cell
precursor) to DN3a (DN = double negative, lacking both CD4 and CD8). Substage markers are shown in Table 1 and Figure 2 (also see Refs.
[25,28]). Commitment occurs between DN2a and DN2b (magenta arrow). At the DN3a stage, cells recombine T-cell receptor (TCR) coding
gene(s), b as shown (Rag1/2 activity: Tcrb) or g and d (not shown), enabling TCR protein(s) to be expressed if the recombination creates an
intact protein reading frame. Signaling through a TCR complex containing TCRb is required (blue arrow, dependent on TCR) for cells to pass
“b selection,” a stringent developmental checkpoint. Successful cells proliferate intensely (curved arrows), lose sensitivity to Notch signaling,
and progress through DN3b, DN4, and ISP intermediates to become DP cells (CD4, CD8 “double positive”), then do not proliferate further. DP
cells recombine the TCRa coding gene (Rag1/2 activity: Tcra), enabling expression of the complete TCRab complex. DP cells are selected for
survival based on whether their TCRab complex has an appropriate affinity interaction with ligands expressed by the thymic epithelium. The
great majority of DP cells are killed intrathymically because of TCRab complex expression failure or failure to bind these ligands at all
(neglect), or because of binding too strongly, triggering apoptosis (negative selection 1). TCR complexes exhibiting appropriate affinity enable
cells to survive and become positively selected (blue arrows, dependent on TCR). Positive selection causes cells to diverge toward functionally
different destinies (lineage choice) and move from the thymic cortex to the medulla. TCR interaction with additional microenvironmental ele-
ments is retested in the medulla, with another round of negative selection for strongly autoreactive cells (negative selection 2). A subset of
autoreactive cells are shunted to a Treg fate rather than death. Surviving cells finally mature and exit the thymus. CD4 SP, CD4: single-positive
cells, mostly helpers. iNKT=invariant NK-like T cells, mostly rapid cytokine producers; CD8 SP=mostly precursors of killer T cells (CTL); Tre-
g=regulatory T cells, immunosuppressive; Th1, Th2, Th17 cells=quasi-lineage subtypes of cytokine-producing helper T cells.
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edly distinct types of precursors that can enter the T-
cell program.
Single-cell analyses of early T-cell development in
mice and humans
T-Cell developmental progressions have now been
studied by single-cell transcriptome analysis using two
kinds of material, both in mouse and in human. First,
the initial wave of T-cell development has been tracked
through gestational time in whole-organ thymus popu-
lations from fetal mouse [41] and first-trimester human
[24,42], following both developing hematopoietic cells
and the epithelial and mesenchymal cells. Second, the
most immature T-cell precursors have been studied in
highly enriched pro-T-cell populations from postnatal
mouse and human thymus, using cell sorting deliber-
ately to exclude nonhematopoietic cells and mature
hematopoietic cells of all lineages, including mature
T cells. In the mouse, Lin−Kithi expression criteria
were used [43], and in human, thymus Lin−CD34+ [44]
or Lin−CD34+CD1a− criteria were used [45] to enrich
for cells in the continuum of the earliest T lineage-
defining stages.
The whole-organ embryologic studies [24,41,42] fol-
lowed thymic cell populations through successive ges-
tational ages after arrival of the first hematopoietic
immigrants. Data from Kernfeld et al. [41] were also
used in a sophisticated computational model to relate
differentiation and population dynamics in the mouse
fetal thymus [46]. The stages beyond the first TCR-
dependent checkpoint (b-selection or gd-selection)
were characterized as they appeared in later gestation
[24,41,42], with special depth in Park et al. [24], and
transcriptome program divergences between ab and gd
lineage T cells were highlighted [24,42]. One postnatal
human cell study [44], too, identified new molecular
markers for b-selection, although notably, these TCR-
dependent stages were deliberately excluded by the sorting
strategies used in other postnatal studies [43,45]. The
postnatal studies focused on relationships of specific tran-
scriptome subsets within the T-lineage developmental pro-
gression, enriching the sequencing data by in vitro
developmental potential assays [43−45], both for T-cell
fate and for developmental alternative branches [43−45].
In the postnatal mouse system, the pseudotime-predicted
precursor−product relationships were validated by real-
time kinetic tests in clonal developmental assays [43].
Taken together, these studies established that pro-T-
cell developmental programs have a highly consistent
conserved regulatory core in the two species. This con-
servation is noteworthy because the cell surface
markers previously used to distinguish stages differ
between mouse and human (Figure 2, top). Population
designations have not used a consistent nomenclature,even in the same species (Table 1). At a deeper level,
transcriptome relationships emerging from these studies
also suggest that the well-used surface markers may
not perfectly coincide with the underlying changes in
regulatory state. While general state changes roughly
correlated with surface change, cells with generally
similar transcriptomes, defined by cluster, often cut
across surface marker-defined boundaries (Table 1).
Single-cell transcriptome analyses generally may pres-
ent interpretation issues, including limited sensitivity,
inadequate clustering of samples containing too few
cells, and treatment of subpopulations with different
cell cycle distributions. Nevertheless, despite ontogenic
and species differences, central features of the intrathy-
mic T-cell developmental pathway were concordant in
all five studies.
A conserved mouse-human developmental trajectory
for pro-T cells
All studies indicated that the earliest hematopoietic
cells in the thymus, including the cells identified as
likely thymus-settling precursors, expressed a consis-
tent core of multipotent progenitor-associated regula-
tory genes (Figure 2), including Hoxa9, Meis1, Hopx,
Lmo2, Mef2c, Hhex, Spi1 (PU.1), Bcl11a, and Lyl1.
These regulatory genes, except Hopx, have previously
been identified as signature features of the precommit-
ment “phase 1” ETP and DN2a stages in the mouse,
based on population RNA analyses [25]. Expression of
these genes in human was similarly confined to the
early intrathymic stages [44,45], associated with cell
surface phenotypes of populations that are not yet T
lineage committed [47,48]. Both in mouse and in
human, they were downregulated before or during com-
mitment, with Hopx, Lmo2, and Meis1 among the earli-
est downregulated and Hhex, Bcl11a, and Spi1 among
the last.
The distinctive T lineage- specific gene expression
profile was activated from specification to commitment,
in human and mouse precursors alike (Figure 2), with
upregulation of the genes encoding the invariant CD3
chains of the TCR complex Cd3g, Cd3d, and Cd3e,
and the transcription factor coding genes Bcl11b and
Lef1. Activation of the Rag genes, to enable TCR gene
locus recombination, occurred at the next stage. Similar
to results using a fluorescent Bcl11b expression indica-
tor in the mouse system [37], the onset of Bcl11b
expression in individual human cells [44,45] corre-
sponded closely to the phenotypic transition associated
with T-cell-lineage commitment (CD44+ to CD44− in
human) [47]. Most remaining phase 1 transcription fac-
tor expression was downregulated, and the functional
impact of loss of the phase 1 transcription factors could
be seen in global motif analysis of the promoters of
genes changing expression in human pro-T cells [45].
Figure 2. A common core program of regulatory gene expression change in mouse and human. A consensus conserved gene expression program
is shared by early T cells, in postnatal mice and humans. The figure shows key regulatory and signaling genes expressed at the corresponding
indicated stages in both mouse and human [43−45]. The framework of stages shown is rooted in the TSP1 precursor trajectory with early intra-
thymic upregulation of CD7 [44,45] and the mouse stage equivalents. Stage markers are shown at the top and aligned as in Table 1. Note that
mouse and human marker expression patterns are slightly different relative to underlying transcriptomes, even when the same marker is tracked
in both. Where possible, each gene in a group is listed in the same row across the figure. (−off) indicates silencing of the gene in this row
expressed in previous stages. Gene names in boldface: T-cell program genes activated in T-lineage precursors by thymic microenvironment.
Gene names in black: genes expressed in common between mouse and human cells at corresponding stages. Gene names in magenta: genes
expressed in indicated stages persist later than in mouse, or lack a mouse equivalent. Gene name in blue: gene expressed at this stage is acti-
vated earlier than in human lineage. (Cd3gde), slight upregulation of the Cd3g, Cd3d, Cd3e gene cluster detectable before commitment, although
greatly enhanced after commitment. (Lyl1), (Mycn) in prethymic: probable expression but not reported directly. Evidence for gene expression in
the prethymic mouse precursor is based on LMPP phenotypes and evidence from genetic studies of the impact of Ccr9 and Ccr7 on thymic
immigration [98,99]. Note that these lists are approximate, not comprehensive, and quantitative changes in expression are not represented. Pat-
terns are gleaned from data in the figures and tables of the references as published [43−45] and not from reanalysis of all genomic data sets
with consistent statistical criteria; comparative levels of genes shown were not always available across all populations. TSP=stage 0 in Table 1;
ETP=stage 1; Spec=specified (stage 2); Com=committed (stage 3); Rearr=TCR gene rearranging (stage 4). Dashed lines in gene lists from Spec
to Com aid in aligning gene groups.
E.V. Rothenberg / Experimental Hematology 2021;95:1−12 5This agreed with previous mouse work indicating the
epigenetic closure of many sites as the phase 1 factor
PU.1 (encoded by Spi1) was turned off [49−51].
The phase 1 genes are usually considered part of
non-T-cell programs, and many are associated with T-
lineage oncogenesis if they are expressed after commit-
ment (reviewed in [25,52,53]) [54,55]. However,single-cell analyses confirmed that they were indeed
conserved physiological components of T-cell develop-
ment, detectable in the absolute majority of individual
cells categorized as ETPs or TSPs in both human and
mouse [43,44]. Importantly, the mouse TSP−ETP pop-
ulations that expressed these genes had high T-lineage
precursor frequencies, »90% among clonogenic cells
Table 1. Alignments between early T-cell precursor nomenclatures
Stage Mouse postnatal Casero, Ha Lavaert Le Zeng Kernfeld
0 (TSP 
Flt3+ ETP)
Thy1 TSP1 and TSP2 Cluster 1 Embryonic ETP Tconv1
1 Flt3 ETP Thy1-Thy2 ETP Cluster 2; Thy2a, 2b Fetal ETP1? TSP-like ETP Tconv1
2 DN2a Thy2 Specified Clusters 2 and 3;
Thy2a, 2b
Fetal ETP1; proliferating ETP Tconv1; Tconv2
Commitment
3 DN2b Thy3 Committed Thy3; clusters 3 and 4 Fetal ETP2; gd T-cell precursor Tconv2; Tconv3
4 DN3a Thy4 Rearranging Clusters 5−11 ab T-cell precursor 2 Tconv3
References [27,28,35,37, 70,96] [30,97] [45] [44] [42] [41]
Approximate correspondences based on consensus of measured developmental potentials and single-cell transcriptome similarities in postnatal T-
cell precursors.
Key cell surface marker landmarks: mouse precursors starting Kithigh, Flt3+, CD44high, CD25−, Thy1−, IL7R−, CD4− CD8− TCR−; human pre-
cursors starting CD34+, (Flt3, Kit?), CD7−, CD1a−, CD44+, CD4−CD8−TCR−. Note that the surface marker distinguishing one “stage” from the
next may not be precisely representative of the timing of the main transcriptome cluster shift:
Mouse, transition stage 0−1: Flt3 downregulation, reduced access to DC fates.
Human, transition stage 0−1: onset of CD7 expression. Note that this definition only characterizes a state transition where the starting point is a
classic TSP1 (CD34+CD7−). CD7+CD34low TSP2 cells [45], likely to represent a separate precursor stream, could appear as an IRF8+CD123+
minor subset within the Thy2+ population [44].
Mouse, transition stage 1−2: onset of CD25, Thy1, IL7R expression (CD7 is turned on within ETP compartment in mice, then off). More pro-
nounced transcriptome change than in human.
Human, transition stage 1−2: increased expression of T-cell signaling genes, for example:
Mouse, commitment: onset of Bcl11b expression (fluorescent reporter), Kit starts to go down.
Human, commitment: onset of CD1a expression (no Cd1a exists in mice), CD7 and CD44 go down.
Mouse, advent of rearrangement: CD44 and Kit off, Rag1 and Rag2 on.
Human, advent of rearrangement: CD34 downregulated, RAG1 and RAG2 on.
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ther verified that the same individual cells turning on
the T-cell program genes were also expressing phase 1
factors [43,44]. When higher-sensitivity methods were
used to overcome the problem of false negatives [43],
the absolute transcript counts from multiple genes in
single cells confirmed that multipotent progenitor-asso-
ciated genes are normally continuing expression in the
great majority of cells as they start the T-cell program
[40].
The early phase 1 compartment was not homoge-
neous. First, the cells represented all cell cycle states,
and second, they comprised more than one developmen-
tal stage (roughly, “TSP” to “specified,” Figure 2). Pseu-
dotime models in both the murine [43] and human
systems [44,45] indicated several different regulatory
processes. Post-TSP ETPs in mice transiently upregu-
lated “non-T-lineage” genes including Tyrobp, Hhex,
and Mpo, often associated with myeloid fate, suggesting
multilineage priming [43]. Similar myeloid-like gene
expression was also found within the early intrathymic
human precursors [44,45]. In the mouse system, the
order of events predicted by the pseudotime model was
verified by in vitro differentiation races between sets of
50−60 single-cell clones with founders sorted from dis-
tinct pseudotime subsets [43]. The results indicated that
cells upregulating these “myeloid” genes were indeed
intermediates on the T-cell pathway. These results
strongly suggest that the thymic microenvironmentdrives several transient regulatory gene expression
changes even before T-cell-lineage commitment.
Variations: Species differences and changes in
ontogeny
These strong overarching similarities did not mean that
the mouse and human regulatory programs were identi-
cal. Earlier population-level measurements had identi-
fied differences in activation of the Notch target Dtx1
[56,57], in regulation of the ILC-promoting regulatory
gene Id2 [30], and in the impacts of strong versus
weak Notch signaling on the TCRab versus TCRgd
lineage choice [58−61]. Single-cell analysis revealed
that the important T-cell transcription factor gene,
TCF7, was activated slightly later in human, accompa-
nying rather than preceding BCL11B as in the mouse
[44,45]. HOXA9 expression in human appeared to per-
sist slightly longer in precommitment human cells, and
IRF8 was also more conspicuously expressed in phase
1 human pro-T cells, while Flt3 and Kit were more
prominent in mouse. One study [44] emphasized sev-
eral additional timing or expression differences in gene
expression.
T-Cell precursors in the mouse thymus are also dif-
ferent in the first ontogenic wave of embryonic T-cell
development than in all subsequent waves [23,62], and
may even arise from precursors that precede appear-
ance of definitive stem cells or from the very earliest
intra-embryonic stem cells [63−66]. First-wave mouse
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(E18) in their more restricted developmental plasticity and
more limited potential for intrathymic proliferation before
they reach differentiation endpoints [67]. In vivo, they
progress through intrathymic stages of T-cell development
faster than any later cohorts of precursors [68,69] and
uniquely give rise to specific skin-homing and mucosal
subsets of TCRgd cells [62]. Interestingly, in the single-
cell studies, the earliest prenatal phase 1 thymocytes were
harder to separate into sequential gene expression sub-
stages than the phase 1 cells from postnatal samples in
both mouse and human [24,41,42]. Phase 1 genes were
expressed, and then were downregulated, but the stages
resolved (re-averaged from the single-cell clusters)
appeared to suggest increased activation of specification
and commitment genes while phase 1 genes were still
active, as compared to equivalent postnatal stages [41,42].
Possibly, this could reflect the statistical problem of sub-
clustering such rare cells. However, this might indicate
that in cells of earlier fetal cohorts, regulatory changes
that otherwise occur sequentially in later waves of T-cell
development are mechanistically accelerated to overlap
(cf. [70]).
Both murine and human single-cell RNA-seq analyses
of first-wave embryonic/fetal thymic populations also con-
curred in showing populations initially rich in NK and
innate lymphoid cell precursors [24,41,42], followed by a
wave of gd-lineage T cells, before ab-lineage T cells
became dominant. Recently, first-wave (E13) mouse ETPs
were also reported to be uniquely bipotent to generate T
and lymphoid tissue inducer cells, a specific subset of
group 3 ILCs [66]. This could confirm an ETP origin for
ILC3-type cells that have been found in the mouse [71]
and early human [24] fetal thymuses, but that disappear
later in ontogeny. As gestation progressed, all these ILC
and “nonconventional” T-cell types became less prominent
[24,41,42], becoming rare in pro-T-cell populations after
birth, as analyzed in the single-cell studies [43−45].
Linking T cells to other hematopoietic lineages:
Precursors and alternatives
Individual T-cell precursors retain intrinsic access to alter-
native myeloid and dendritic -cell fates for many cell
cycles after arriving in the thymus [21,32−34,72−75],
albeit losing B-cell potential much earlier [33,34,74].
Their myeloid or DC competence is readily illustrated by
removing them from the thymus and from Notch signaling.
Thus, they appear to arise from lymphomyeloid precursors
[38,76−78] or else from common lymphoid precursors
that somehow regain myeloid potential transiently within
the thymus. Within the thymus, despite this potential,
Notch signaling inhibits their myeloid differentiation effi-
ciently [75,79−81], and the thymus is poor in myeloid-
supporting cytokines (in contrast to its abundance of lym-
phoid-supporting IL-7).A strongly debated question has been whether any of
the same precursors that generate T cells normally gen-
erate myeloid or dendritic cells also, within the thymus
microenvironment [82,83]. Granulocytic-committed
precursors appear consistently as a minority within
mouse ETP populations [43,75], and may be generated
in vivo from some ETPs [75]. Much evidence has
accumulated to suggest that thymic dendritic cells
could emerge, at least in part, from the same thymic
immigrants as T cells [21,84,85]. Plasmacytoid den-
dritic cells (pDCs) are particularly prominent and share
with T-cell precursors their strong use of E-protein
transcription factors [86], leading to some expression
of “cross-lineage” genes [87,88]. The potential for pDC
development has long been noted: when Notch1 is
mutationally disrupted specifically within T-cell precur-
sors, pDCs emerge from these precursors within the
mouse thymus [81], and human thymocytes cultured
without Notch signaling also generate pDCs [87]. A
lower-intensity Notch signaling niche has now been
described in the human thymus that appears to be natu-
rally permissive for pDC development [89].
Single-cell analyses confirm that pDCs are reproduc-
ibly found in postnatal human thymus [44,45], and
some uncommitted early pro-T cells in the postnatal
human thymus are apparently transcriptionally pre-
primed for a pDC developmental path [44]. One pro-T-
cell subset distinctively expressing the IL-3 receptor
subunit CD123 and the transcription factor IRF8 exhib-
ited a greater ability to generate pDC cells than any
other non-T alternative [44], supporting earlier evi-
dence for some pDC-biased precursors in the thymus
[89]. Evidence discussed below indicates that a sepa-
rate prethymic precursor stream [45] might be the
source of the CD123+ pro-T cells. Thus, a pre-ordained
pDC bias may characterize one particular stream of
precursors supplying the human thymus.
If thymus-seeding cells have granulocytic and pDC
potential, then where should they fall in the spectrum of
bone marrow, cord blood, and fetal liver hematopoietic
precursors? In human, prior studies had used varied com-
binations of CD38, CD45RA, ITGB7, CD7, CD10, CD127
(IL-7 receptor a chain), and/or CD2 for enrichment and
fractionation of possible T-cell precursors among CD34+
cells [11,13−15], but it was not clear whether all assays
were identifying the same precursors. In the mouse, an ele-
gant barcode-based lineage-tracing analysis (“LARRY”)
identified transcriptomes of cells with the highest precur-
sor activity for T-cell generation in vivo, finding them
close to DC precursors and sharing with them enriched
expression of Flt3, Ighm, and Dntt [12]. Other important
data sets came previously from bulk microarray and RNA-
seq measurements and single-cell analyses of finely dis-
sected hematopoietic progenitors [8,9,13,14, 17,76], but
explicit quantitative comparison with early intrathymic
Figure 3. Potential alternative origins for T-cell precursors. Shown are distinct properties of two alternative sources of prethymic TSPs, for contrast with
the TSP1 ("Pre") cells shown in Figure 2. Below main sequence: TSP2 cells. TSP1 cells have more readily detectable counterparts in mouse and human
ETP populations, but TSP2-like cells [14] have been proposed as T-cell precursors in the bone marrow because of their apparently T lineage-affiliated
CD7+ phenotype [14,15]. They lack the CD10 (MME), Hoxa9, and Hopx expression of TSP1 cells, and express regulatory genes that seemingly clash with
the T-cell program (Irf8, SpiB, Id2), yet rapidly develop into T-lineage cells in assays in vitro and in humanized mice [14,15]. The figure shows the distinct
transcriptomes of the TSP2 cells from [45] and their high propensity to act as bipotent T-pDC precursors [44,45]. Above the main sequence: first-wave
fetal TSPs (1st wv Pre). Functional studies in mice [16,17] as well as single-cell transcriptome alignments in humans [42] indicate that first-wave prethy-
mic precursors express IL7R (CD127) and show preferential ability to generate ILCs as well as T cells [24,41,42,66]. These cells are rare, but transcrip-
tome analysis shows TSP2-like Irf8, Tyrobp, and Il3ra (CD123) expression.
8 E.V. Rothenberg / Experimental Hematology 2021;95:1−12populations was lacking until the recent studies, in which
single-cell transcriptomes of primitive intrathymic cells
were matched with single-cell clusters from blood or fetal
liver to find TSP candidates based on similarity [24,42,
44,45]. In human fetuses, the most immature fetal thymo-
cyte transcriptomes were found to adjoin a continuum of
states between lymphomyeloid and CLP-like fetal liver
cells [24]. On deeper analysis, the results suggested three
possible types of cells that may seed the human thymus: at
least two different precursor types for postnatal thymus
and a third, probably distinct type for early fetal thymus.
In postnatal human blood, two different thymus-
seeding candidates were identified [45], each with a
counterpart within the thymus. Both expressed multiple
progenitor transcription factors and CD74, but they
were otherwise distinct. One of the precursors, TSP1,
was CD10+, CD7−, and ITGB7−, lacked expression
of Notch-inducible genes, and expressed a stem/progenitor-like set of genes. The other, TSP2, was
CD10−CD7+ and ITGB7+, high in interferon response
gene and IRF8 expression, and lower in expression of
HOXA9 and CD34, and expressed Notch target genes
(CD7, CD3E) even before reaching the thymus [45].
Although their CD7 and CD3E expression resembled
features of most intrathymic “specified” cells, their
other properties did not. The possibility of prethymic
Notch priming was consistent with some previous evi-
dence from mouse and human alike [15,90]. These
IRF8high TSP2 cells might be the source of pro-T cells
with high pDC potential. Despite their differences,
however, TSP1 and TSP2 were functionally indistin-
guishable in T-cell potential [45] (Figure 3). Both
effectively generated T-lineage cells in T-cell condi-
tions in stromal culture, and both could similarly
repopulate fetal thymus organ cultures in a G-protein-
coupled receptor-dependent way, consistent with the
E.V. Rothenberg / Experimental Hematology 2021;95:1−12 9known CCR7- or CCR9- dependent mechanism in vivo
[45]. A third apparent TSP-like population was found in
the very early fetal liver (8 pcw) [42]. These cells were
TSP2-like, with high IRF8 and CD123 (IL3RA) expres-
sion. However, they also expressed IL7R [42], like the dis-
tinctive first-wave T-cell precursors in mice [16,23], but
unlike postnatal TSP1 and TSP2, and also contrasting with
cord blood, where IL7R protein reportedly marks precur-
sors preferring a B-cell fate [14]. If these were indeed the
earliest-wave fetal TSP source, then they should give rise
to special fetal-restricted ILC and gd cell lineages, as well
as conventional T cells and possible pDCs.
Thus, two or more distinct regulatory states are consis-
tent with an ability to migrate to the thymus and give rise
to T cells once in the thymus, and they are likely to come
with distinct repertoires of alternative lineage potentials.
Concluding remarks
Single cell insights into T-cell development in its
hematopoietic context
This review has focused on aspects of T-cell develop-
ment that link it to the rest of hematopoiesis. In fact,
the recent studies discussed here extend well beyond
this focus. For example, refs. [24,41,42] also character-
ize intrathymic stromal cell types (also see ref. [91] for
pioneering detail on epithelial cell types) and signaling
ligand/receptor pairs potentially mediating communica-
tion of microenvironmental cells with T-cell precursors
[24,42]. Some focus on T-cell receptor repertoire selec-
tion in detail [24] and on the regulatory divergences at
the split between TCRab and TCRgd lineages
[24,42,44]. Another recent single-cell transcriptome
study has focused in depth on the complex generation
of gd T cells, directly comparing programs for emer-
gence of different gd lineages in late-fetal and adult
mice [91a]. These topics interface with much larger
immunologic literatures, as well as with examination of
gene regulatory mechanisms controlling developmental
progressions, including roles of transcription factors
individually (reviewed in Hosokawa and Rothenberg
[4]) and epigenetic changes [49,50,92,93].
Other recent studies, moreover, have now used sin-
gle-cell transcriptome analyses to reveal the crucial
role of the TCF1 transcription factor (encoded by Tcf7)
both in early intrathymic T-cell development [94] and
in the corresponding stages of ILC2 development in
the bone marrow [95]. Lack of TCF1 was reported to
divert DN1 and DN2/3 pro-T cells into altered, distinct
gene expression states, prone to leukemic transforma-
tion [94], while TCF1 was found to be indispensable
for ILC precursors to undergo transition to lineage
commitment, a regulatory shift homologous in many
details to commitment in pro-T cells [95]. The similari-
ties between the ILC and T-cell programs remain afascinating challenge to facile pictures of how the thy-
mus triggers T-cell development.
The next challenge is to link the origins of the T-
cell program more accurately to the diverse span of
progenitor states in the bone marrow [11,13,15]. While
factors such as SOX4, ID2, and SATB1 have been cor-
related with lymphoid precursor activity [13,15], the
evidence reviewed here suggests a different set of
genes distinctive for thymus-seeding precursors and the
genuine possibility that more than one such prethymic
source exists. The new richness of single-cell transcrip-
tome evidence suggests fresh ways to identify the sour-
ces of T-cell precursors and to reveal what determines
their T-lineage competence.Conflict of interest disclosure
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